Verastem, Inc. Earnings Per Share (Diluted)
Verastem, Inc. (VSTM) reported Earnings Per Share (Diluted) of -$0.35 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-06
- Verastem, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.35.
- Verastem, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.46.
- Verastem, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$1.35.
- Verastem, Inc. earnings per share, diluted for the quarter ending 2025-06-30 was -$0.62.
- Verastem, Inc. earnings per share, diluted for fiscal 2025 was -$3.02.
- Verastem, Inc. earnings per share, diluted for fiscal 2024 was -$3.66.
- Verastem, Inc. earnings per share, diluted for fiscal 2023 was -$3.96.
- Verastem, Inc. earnings per share, diluted for fiscal 2022 was -$4.57.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$0.35 10-Q · filed 2026-08-06 | -$0.81 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | -$0.46 10-Q · filed 2026-05-07 | ||||
| 2025-12-31 | -$3.02 10-K · filed 2026-03-04 | ||||
| 2025-09-30 | -$1.35 10-Q · filed 2025-11-04 | -$2.73 10-Q · filed 2025-11-04 | |||
| 2025-06-30 | -$0.62 10-Q · filed 2026-08-06 | -$1.41 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | -$0.96 10-Q · filed 2026-05-07 | ||||
| 2024-12-31 | -$3.66 10-K · filed 2026-03-04 | ||||
| 2024-09-30 | -$0.60 10-Q · filed 2025-11-04 | -$2.11 10-Q · filed 2025-11-04 | |||
| 2024-06-30 | -$0.31 10-Q · filed 2025-08-07 | -$1.57 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | -$1.26 10-Q · filed 2025-05-13 | ||||
| 2023-12-31 | -$3.96 10-K · filed 2026-03-04 | -$3.93 10-K · filed 2024-03-14 | |||
| 2023-09-30 | -$0.75 10-Q · filed 2024-11-06 | -$2.93 10-Q · filed 2024-11-06 | |||
| 2023-06-30 | -$1.37 10-Q · filed 2024-08-08 | -$2.32 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | -$0.08 10-Q · filed 2024-05-09 | ||||
| 2022-12-31 | -$4.57 10-K · filed 2025-03-20 | -$0.38 10-K · filed 2023-03-14 | |||
| 2022-09-30 | -$0.09 10-Q · filed 2022-11-03 | -$0.30 10-Q · filed 2022-11-03 | |||
| 2022-06-30 | -$0.12 10-Q · filed 2022-08-08 | -$0.21 10-Q · filed 2022-08-08 | |||
| 2022-03-31 | -$0.09 10-Q · filed 2024-05-09 | ||||
| 2021-12-31 | -$4.90 10-K · filed 2024-03-14 | -$0.41 10-K · filed 2022-03-28 | |||
| 2021-09-30 | -$0.13 10-Q · filed 2022-11-03 | -$0.31 10-Q · filed 2022-11-03 | |||
| 2021-06-30 | -$0.10 10-Q · filed 2022-08-08 | -$0.19 10-Q · filed 2022-08-08 | |||
| 2021-03-31 | -$0.09 10-Q · filed 2022-05-09 | ||||
| 2020-12-31 | -$0.12 10-K · filed 2021-03-18 | -$0.44 10-K · filed 2023-03-14 | |||
| 2020-09-30 | $0.08 10-Q · filed 2021-11-04 | -$0.32 10-Q · filed 2021-11-04 | |||
| 2020-06-30 | -$0.14 10-K · filed 2021-03-18 | ||||
| 2020-03-31 | -$0.35 10-K · filed 2021-03-18 | ||||
| 2019-12-31 | -$0.51 10-K · filed 2021-03-18 | -$2.00 10-K · filed 2022-03-28 | |||
| 2019-09-30 | -$0.41 10-K · filed 2021-03-18 | -$1.49 10-Q · filed 2020-11-09 | |||
| 2019-06-30 | -$0.57 10-K · filed 2021-03-18 | ||||
| 2019-03-31 | -$0.52 10-K · filed 2021-03-18 | ||||
| 2018-12-31 | -$0.37 10-K · filed 2020-03-11 | -$1.37 10-K · filed 2021-03-18 | |||
| 2018-09-30 | -$0.29 10-K · filed 2020-03-11 | ||||
| 2018-06-30 | -$0.30 10-K · filed 2020-03-11 | ||||
| 2018-03-31 | -$0.41 10-K · filed 2020-03-11 | ||||
| 2017-12-31 | -$1.76 10-K · filed 2020-03-11 | ||||
| 2016-12-31 | -$0.99 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |